NCT01009853已完成1 期
A Single Dose, 1-Period, 1-Treatment Study of Codeine Sulfate 15 mg Tablets Under Steady State Conditions
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 34
- 试验地点
- 1
- 主要终点
- bioequivalence determined by statistical comparison Cmax
研究概览
简要总结
Study to characterize the steady-state pharmacokinetics of codeine and its metabolites morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G) after oral administration of Roxane Laboratories' codeine sulfate tablets administered at a dose of 15 mg Q4H x 5 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to codeine sulfate or any comparable or similar product.
结局指标
主要结局
bioequivalence determined by statistical comparison Cmax
时间窗: 6 days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled ReleasePainNCT00994383Roxane Laboratories36
终止
2 期
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8Cocaine AbuseOpiate DependenceNCT00218036The University of Texas Health Science Center, Houston54
已完成
1 期
Single Dose IV Methadone for Post-Op PainPain, PostoperativeNCT05425420Kanecia Obie Zimmerman22
已完成
1 期
Pharmacotherapy & CM for Opioid and Cocaine DependenceCocaine DependenceNCT00838981Yale University91
已完成
1 期
Pharmacokinetics of Oxycodone and PF614 Co-Administered With NafamostatPharmacokineticsNCT05090280Ensysce Biosciences111